Having a clear endpoint in mind makes the daily discomfort more bearable
Factors such as dosage, consistency, lifestyle habits, and overall health can play a significant role
Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr M (2009) Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease
The STEP 5 clinical trial (using the Wegovy formulation of semaglutide) confirmed safety and effectiveness for up to 2 years, with participants maintaining 15.2% body weight reduction compared to just 2.6% with placebo